chr3-4787891-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378452.1(ITPR1):​c.6616-56T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 1,269,810 control chromosomes in the GnomAD database, including 9,589 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.082 ( 643 hom., cov: 31)
Exomes 𝑓: 0.12 ( 8946 hom. )

Consequence

ITPR1
NM_001378452.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.39

Publications

5 publications found
Variant links:
Genes affected
ITPR1 (HGNC:6180): (inositol 1,4,5-trisphosphate receptor type 1) This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
ITPR1 Gene-Disease associations (from GenCC):
  • aniridia-cerebellar ataxia-intellectual disability syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • spinocerebellar ataxia type 29
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
  • spinocerebellar ataxia type 15/16
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 3-4787891-T-C is Benign according to our data. Variant chr3-4787891-T-C is described in ClinVar as Benign. ClinVar VariationId is 1240984.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITPR1NM_001378452.1 linkc.6616-56T>C intron_variant Intron 51 of 61 ENST00000649015.2 NP_001365381.1
ITPR1NM_001168272.2 linkc.6571-56T>C intron_variant Intron 50 of 60 NP_001161744.1
ITPR1NM_001099952.4 linkc.6472-56T>C intron_variant Intron 48 of 58 NP_001093422.2
ITPR1NM_002222.7 linkc.6427-56T>C intron_variant Intron 47 of 57 NP_002213.5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITPR1ENST00000649015.2 linkc.6616-56T>C intron_variant Intron 51 of 61 NM_001378452.1 ENSP00000497605.1
ITPR1ENST00000354582.12 linkc.6592-56T>C intron_variant Intron 51 of 61 5 ENSP00000346595.8
ITPR1ENST00000648266.1 linkc.6589-56T>C intron_variant Intron 51 of 61 ENSP00000498014.1
ITPR1ENST00000650294.1 linkc.6574-56T>C intron_variant Intron 50 of 60 ENSP00000498056.1
ITPR1ENST00000443694.5 linkc.6571-56T>C intron_variant Intron 50 of 60 1 ENSP00000401671.2
ITPR1ENST00000648309.1 linkc.6544-56T>C intron_variant Intron 48 of 58 ENSP00000497026.1
ITPR1ENST00000357086.10 linkc.6472-56T>C intron_variant Intron 48 of 58 1 ENSP00000349597.4
ITPR1ENST00000456211.8 linkc.6427-56T>C intron_variant Intron 47 of 57 1 ENSP00000397885.2
ITPR1ENST00000648038.1 linkc.4378-56T>C intron_variant Intron 31 of 41 ENSP00000497872.1
ITPR1ENST00000648431.1 linkc.3916-56T>C intron_variant Intron 29 of 38 ENSP00000498149.1
ITPR1ENST00000648212.1 linkc.3523-56T>C intron_variant Intron 27 of 38 ENSP00000498022.1

Frequencies

GnomAD3 genomes
AF:
0.0818
AC:
12404
AN:
151686
Hom.:
644
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0246
Gnomad AMI
AF:
0.157
Gnomad AMR
AF:
0.0684
Gnomad ASJ
AF:
0.108
Gnomad EAS
AF:
0.000964
Gnomad SAS
AF:
0.0288
Gnomad FIN
AF:
0.0874
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.126
Gnomad OTH
AF:
0.0846
GnomAD4 exome
AF:
0.117
AC:
131215
AN:
1118006
Hom.:
8946
AF XY:
0.115
AC XY:
64700
AN XY:
564900
show subpopulations
African (AFR)
AF:
0.0199
AC:
507
AN:
25532
American (AMR)
AF:
0.0504
AC:
1568
AN:
31140
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
2508
AN:
22958
East Asian (EAS)
AF:
0.000168
AC:
6
AN:
35694
South Asian (SAS)
AF:
0.0328
AC:
2286
AN:
69720
European-Finnish (FIN)
AF:
0.0916
AC:
4620
AN:
50452
Middle Eastern (MID)
AF:
0.0639
AC:
317
AN:
4964
European-Non Finnish (NFE)
AF:
0.138
AC:
114282
AN:
828950
Other (OTH)
AF:
0.105
AC:
5121
AN:
48596
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
5610
11220
16831
22441
28051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3644
7288
10932
14576
18220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0817
AC:
12402
AN:
151804
Hom.:
643
Cov.:
31
AF XY:
0.0779
AC XY:
5781
AN XY:
74168
show subpopulations
African (AFR)
AF:
0.0245
AC:
1016
AN:
41398
American (AMR)
AF:
0.0682
AC:
1040
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.108
AC:
374
AN:
3470
East Asian (EAS)
AF:
0.000966
AC:
5
AN:
5176
South Asian (SAS)
AF:
0.0294
AC:
141
AN:
4790
European-Finnish (FIN)
AF:
0.0874
AC:
921
AN:
10538
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.126
AC:
8566
AN:
67878
Other (OTH)
AF:
0.0833
AC:
175
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
551
1101
1652
2202
2753
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.112
Hom.:
1784
Bravo
AF:
0.0779
Asia WGS
AF:
0.0160
AC:
56
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.56
DANN
Benign
0.36
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17786144; hg19: chr3-4829575; API